Clinical Trials Logo

Diabetic Retinopathy clinical trials

View clinical trials related to Diabetic Retinopathy.

Filter by:

NCT ID: NCT01744132 Completed - Diabetes Mellitus Clinical Trials

Overcoming Barriers in Vision Care Utilization of African Americans With Diabetes

Start date: October 2012
Phase: N/A
Study type: Interventional

The goal of this project is to implement a Collaborative Translational Research Center (TRC) Network Study which aims to assure optimal two-way communication between ophthalmologists and their patients' primary care physicians (PCP). The Collaborative TRC Network Study will have 2 objectives: - To design and develop common research protocols to develop a 4-year retrospective database (2007-2010) that compiles electronic billing and medical chart information that can be used to study individual-level, clinical-level and system-level factors that impact access to and quality of vision care; - To evaluate adherence to dilated fundus exams (DFEs) follow-up as the primary measureable quality indicator, and its relationship to the patients' demographics, ethnicity, socioeconomic status (SES), severity of diabetic retinopathy (DR), other ocular and medical co-morbidities, presence of HA1C, and primary care provider (PCP) communication. By enhancing communication and strengthening the clinical information exchanged between PCPs and eye care professionals, this Collaborative TRC Network study will help to overcome barriers to obtaining ongoing DFEs and reduce disparities in vision care utilization.

NCT ID: NCT01743781 Completed - Glaucoma Clinical Trials

Uptake of Comprehensive Eye Examination Trial

Start date: July 2013
Phase: N/A
Study type: Interventional

1. To evaluate a educational intervention promoting acceptance of comprehensive eye examination in rural Guangdong. 2. To evaluate the impact of acceptance of comprehensive eye examination in rural Guangdong.

NCT ID: NCT01737957 Terminated - Clinical trials for Proliferative Diabetic Retinopathy

Safety and Efficacy of Low-Fluence PRP for PDR

Start date: November 2012
Phase: N/A
Study type: Interventional

To determine the safety and efficacy of a single session of low-fluence panretinal photocoagulation when compared to full-fluence PRP. Hypothesis: a single-session of low-fluence PRP will be safe regarding the progression of macular edema and the presence of adverse events, and will efficiently induce regression of neovascularization.

NCT ID: NCT01736059 Active, not recruiting - Clinical trials for Diabetic Retinopathy

Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

Start date: July 2012
Phase: Phase 1
Study type: Interventional

This pilot study is to determine whether it would be safe and feasible to inject CD34+ stem cells from bone marrow into the eye as treatment for patients who are irreversibly blind from various retinal conditions.

NCT ID: NCT01728883 Completed - Clinical trials for Diabetic Retinopathy

Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study

DRAMA
Start date: April 2013
Phase: N/A
Study type: Observational

The purpose of this study is to determine the effect of enhancements to the myVisionTrack® in regards to patient compliance and test-retest variability. Additionally, the ability of myVisionTrack® to detect changes in vision function will be evaluated.

NCT ID: NCT01726075 Completed - Clinical trials for Diabetic Retinopathy

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

EUROCONDOR
Start date: February 2013
Phase: Phase 2/Phase 3
Study type: Interventional

To assess whether neuroprotective drugs administered topically (somatostatin and brimonidine) are able to prevent or arrest the development and progression of neurodegenerative changes

NCT ID: NCT01724554 Completed - Clinical trials for Proliferative Diabetic Retinopathy

Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion

ANDROID
Start date: November 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to look at how effective, safe, and well tolerated Intravitreal Aflibercept Injection is in subjects with Central Retinal Vein Occlusion (CRVO) or Proliferative Diabetic Retinopathy (PDR).

NCT ID: NCT01724385 Completed - Clinical trials for Proliferative Diabetic Retinopathy

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy

Start date: August 2012
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy of intravitreal bevacizumab injections for treatment of proliferative diabetic retinopathy (PDR) with new dense vitreous hemorrhage (VH) after previous full panretinal photocoagulation (PRP).

NCT ID: NCT01717937 Terminated - Clinical trials for Diabetic Retinopathy

Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging

PVOCT
Start date: February 2013
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether phase variance optical coherence tomography (PV-OCT), a software-based optical coherence tomography(OCT) image processing technology, can be used to generate angiographic images of the retinochoroidal vasculature that are comparable to those produced by fluorescein angiography (FA), the current gold standard diagnostic test.

NCT ID: NCT01694212 Completed - Cataract Clinical Trials

Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy

Start date: October 2012
Phase: N/A
Study type: Interventional

Diabetes has many negative effects on patients' general health. Among many other consequences it speeds up the cataract formation and that is why diabetic patients need cataract surgery very often. The known side effect of cataract surgery even in otherwise healthy patients is postoperative edema of the back of the eye (what causes decrease of vision), which has greater incidence especially in patients who have diabetic eye problems. The cause of that might be the intraocular inflammation which was previously demonstrated to be significantly more prominent in patients with untreated diabetic eye problems. Therefore we will examine if the 7 day use of anti-inflammatory eye drops prior to the cataract surgery prevent the formation of the edema of the back of the eye.